DOCS — Doximity, Inc. stock price, charts and financials

NYSE·Healthcare·Medical - Healthcare Information Services·USA

Latest market price

21.89

+0.23+1.06%

Overview Short InterestFilings

DOCSQT30Doximity, Inc.·NYSE

Overview Short InterestFilings

21.89+1.06%

Earnings

Up 1.1% — Earnings due 2026-08-06 — pre-report positioning.

Medium confidence

Loading chart...

Screen all →

WAY+4.90%$23.77 PRVA+0.00%$23.79 TXG+1.81%$47.86 HNGE+2.28%$79.42 PGNY-0.16%$31.48 HTFL+1.94%$27.28 WGS+4.48%$70.90 TEM+2.17%$47.05

Snapshot

Index	-	P/E	22.11	EPS (ttm)	0.99	Insider Own	32.31%	Shs Outstand	187.03M	Perf Week	2.10%

Market Cap	4.09B	Forward P/E	13.73	EPS next Y	1.59	Insider Trans	-0.04%	Shs Float	181.35M	Perf Month	-4.24%

Enterprise Value	3.35B	PEG	2.21	EPS next Q	-	Inst Own	-	Short Float	11.43%	Perf Quarter	-12.05%

Income	196.00M	P/S	6.35	EPS this Y	44.79%	Inst Trans	-	Short Ratio	5.08	Perf Half Y	-41.30%

Sales	645.00M	P/B	4.30	EPS next Y	11.19%	ROA	17.45%	Short Interest	20.73M	Perf YTD	-50.56%

Book/sh	5.08	P/C	5.47	EPS next 5Y	10.02%	ROE	19.36%	52W High	76.51 -71.39%	Perf Year	-61.82%

Cash/sh	4.00	P/FCF	12.32	EPS past 3/5Y	22.74% 52.20%	ROIC	17.36%	52W Low	17.15 27.64%	Perf 3Y	-38.29%

Dividend Est.	-	EV/EBITDA	12.61	Sales past 3/5Y	15.46% 25.52%	Gross Margin	89.09%	Volatility	3.46% 3.78%	Perf 5Y	-63.17%

Dividend TTM	-	EV/Sales	5.20	EPS Y/Y TTM	-10.81%	Oper. Margin	33.33%	ATR (14)	0.90	Perf 10Y	-

Dividend Ex-Date	-	Quick Ratio	6.09	Sales Y/Y TTM	13.16%	Profit Margin	30.40%	RSI (14)	54.83	Recom	2.61

Dividend Gr. 3/5Y	-	Current Ratio	6.09	EPS Q/Q	-42.22%	SMA20	1.93%	Beta	1.20	Target Price	27.63

Payout	0.00%	Debt/Eq	0.01	Sales Q/Q	5.07%	SMA50	3.83%	Rel Volume	0.68	Prev Close	21.66

Employees	880	LT Debt/Eq	0.01	Earnings	Aug 06	SMA200	-33.75%	Avg Volume	4.06M	Price	21.89

IPO Date	Jun 24, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-8.21% 0.93%	Net Debt/EBITDA	-0.79	Volume	2,743,312	Change	1.06%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Jun-29-26	Downgrade	B of A Securities	Buy → Underperform
May-15-26	Downgrade	Barclays	Overweight → Equal Weight	$20
May-14-26	Reiterated	Robert W. Baird		$18
May-14-26	Reiterated	Canaccord Genuity	Buy	$34 → $30
May-14-26	Downgrade	Wells Fargo	Overweight → Equal Weight	$32 → $18
May-14-26	Downgrade	Jefferies	Buy → Hold	$19
May-14-26	Reiterated	Mizuho	Neutral	$45 → $26
May-14-26	Reiterated	Goldman Sachs	Neutral	$34 → $24
May-14-26	Downgrade	Keybanc	Overweight → Sector Weight
May-14-26	Reiterated	Needham	Buy	$55 → $27

Latest News

Aug-04-26

Aug-04-2612:13PM

2 Profitable Stocks to Keep an Eye On and 1 We Turn DownYahoo

Jul-27-26

Jul-27-2610:53PM

1 Stock Under $50 to Consider Right Now and 2 We IgnoreYahoo

07:16PM

Doximity (DOCS) Laps the Stock Market: Here's Whyzacks.com

04:13AM

California Public Employees Retirement System Raises Stock Holdings in Doximity, Inc. $DOCSdefenseworld.net

Jul-24-26

Jul-24-2601:00AM

Have We Entered A Stealth Bear Market?SeekingAlpha

Jul-22-26

Jul-22-2601:15AM

Contrasting OBOOK (NASDAQ:OWLS) & Doximity (NYSE:DOCS)defenseworld.net

Jul-17-26

Jul-17-2607:16PM

Doximity (DOCS) Declines More Than Market: Some Information for Investorszacks.com

03:26PM

Reasons to Retain Doximity Stock in Your Portfolio for Nowzacks.com

Jul-16-26

Jul-16-2608:01PM

Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026Yahoo

Jul-15-26

Jul-15-2602:26PM

Doximity Outranks OpenEvidence, Frontier Models in Independent Stanford-Harvard Study of Clinical AI Safetybusinesswire.com

Jul-10-26

Jul-10-2607:16PM

Doximity (DOCS) Stock Declines While Market Improves: Some Information for Investorszacks.com

Jul-04-26

Jul-04-2604:14AM

Doximity’s Shift Into Value Indices Might Change The Case For Investing In DOCSYahoo

Jul-03-26

Jul-03-2612:32PM

Did Doximity Inc. Insiders Breach their Fiduciary Duties to Shareholders?prnewswire.com

Jun-30-26

Jun-30-2605:33AM

Doximity: Everyone Is Focused On The Guidance While Missing The Valuation And AI Storiesseekingalpha.com

Jun-29-26

Jun-29-2601:46PM

Doximity's AI Expansion Raises Execution Risks: Analystbenzinga.com

Company

Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2026 3/31/2026	FY 2025 3/31/2025	FY 2024 3/31/2024	FY 2023 3/31/2023	FY 2022 3/31/2022	FY 2021 3/31/2021	FY 2020 3/31/2020	FY 2019 3/31/2019
Total Revenue	645	645	570	475	419	344	207	116	86
Cost of Goods Sold Incl. D&A	70	70	56	51	53	40	31	15	11
Gross Profit	574	575	515	425	366	304	176	101	75
Selling, General and Administrative Excl. Other	229	229	191	171	160	128	79	47	40
Research and Development	131	131	93	82	80	62	44	32	27
Other Operating Expense	-1	0	3	8	0	0	-1	0	1
Operating Income	216	215	228	164	125	114	53	22	7
Interest Expense	0	0	0	0	0	0	0	0	0
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	35	35	36	21	8	0	4	1	1
Net Income Before Taxes	250	250	264	185	133	114	58	24	8
Income Taxes	54	54	40	38	20	-41	8	-6	0
Consolidated Net Income	196	196	223	148	113	155	50	30	8
Net Income From Continuing Operations	196	196	223	148	113	155	50	30	8
Net Income	196	196	223	148	113	155	50	30	8
EPS (Recurring)	1.04	1.05	1.19	0.78	0.58	0.81	0.12	0.06	0.00
EPS (Basic, Before Extraordinaries)	1.04	1.05	1.19	0.78	0.58	0.81	0.12	0.06	0.00
EPS (Diluted)	0.99	0.98	1.11	0.72	0.53	0.70	0.12	0.06	0.00
EBITDA	266	264	241	182	143	119	55	23	7
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	22.11	23.78	52.28	37.38	61.09	74.41	—	—	—
Price To Sales Ratio	6.28	6.76	19.04	10.76	14.91	24.68	—	—	—
Gross Margin	88.99	89.15	90.35	89.47	87.35	88.37	85.02	87.07	87.21
Operating Margin	33.49	33.33	40.00	34.53	29.83	33.14	25.60	18.97	8.14
Net Margin	30.39	30.39	39.12	31.16	26.97	45.06	24.15	25.86	9.30
Shares Outstanding	185	187	187	190	193	163	178	182	182
Market Capitalization	4,050	4,357	10,852	5,113	6,249	8,491	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sitaram Siddharth	Chief Accounting Officer	Jul 15 '26	Option Exercise	0.00	4,800	0	4,800	Jul 20
Sitaram Siddharth	Chief Accounting Officer	Jul 15 '26	Sale	22.02	1,732	38,139	93,774	Jul 20
Sitaram Siddharth	Interim PAO	Jun 08 '26	Sale	20.41	2,444	49,882	90,706	Jun 10
Sitaram Siddharth	Interim PAO	Jun 08 '26	Option Exercise	0.00	5,000	0	5,000	Jun 10
Sitaram Siddharth	Interim PFO and PAO	May 11 '26	Sale	25.77	2,309	59,503	89,396	May 13
Sitaram Siddharth	Interim PFO and PAO	May 11 '26	Option Exercise	0.00	5,000	0	5,000	May 13
Wampler Kira Scherer	Director	May 07 '26	Sale	26.06	9,000	234,540	19,839	May 08
Wampler Kira Scherer	Director	May 07 '26	Option Exercise	0.00	9,000	0	9,000	May 08
Sitaram Siddharth	Interim PFO and PAO	Apr 10 '26	Sale	21.09	2,427	51,185	86,705	Apr 14
Sitaram Siddharth	Interim PFO and PAO	Apr 10 '26	Option Exercise	0.00	5,000	0	5,000	Apr 14
Sitaram Siddharth	Interim PFO and PAO	Mar 10 '26	Sale	25.37	2,319	58,833	84,132	Mar 12
Sitaram Siddharth	Interim PFO and PAO	Mar 10 '26	Option Exercise	0.00	5,000	0	5,000	Mar 12
Sitaram Siddharth	Interim PFO and PAO	Feb 10 '26	Sale	27.88	2,282	63,622	81,451	Mar 12
Sitaram Siddharth	Interim PFO and PAO	Feb 10 '26	Option Exercise	0.00	5,000	0	5,000	Mar 12
Wampler Kira Scherer	Director	Mar 03 '26	Sale	26.00	2,000	52,000	19,839	Mar 05

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.